Singapore markets closed

CytomX Therapeutics Inc (6C1.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
1.4840-0.0120 (-0.80%)
At close: 09:54PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
101,214
101,214
53,163
37,312
68,427
Operating expenses
Research development
77,680
77,680
111,649
114,194
112,936
Selling general and administrative
30,018
30,018
42,849
39,160
36,031
Total operating expenses
107,698
107,698
154,498
153,354
148,967
Operating income or loss
-6,484
-6,484
-101,335
-116,042
-80,540
Total other income/expenses net
-30
-30
340
-83
-27
Income before tax
3,323
3,323
-99,317
-115,870
-78,731
Income tax expense
3,892
3,892
0
0
-13,911
Income from continuing operations
-569
-569
-99,317
-115,870
-64,820
Net income
-569
-569
-99,317
-115,870
-64,820
Net income available to common shareholders
-569
-569
-99,317
-115,870
-64,820
Basic EPS
-0.15
-
-1.51
-1.81
-1.40
Diluted EPS
-0.15
-
-1.51
-1.81
-1.40
Basic average shares
69,945
-
65,740
64,147
46,146
Diluted average shares
69,945
-
65,740
64,147
46,146